Longfellow Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Longfellow Investment Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-533	Closed	-$36K	–	378
2022 Q3	$36K	Buy	+533	New	+$29.4K	0.01%	239

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Longfellow Investment Management's GBT Position: Q4 2022 in Review

Longfellow Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 533 shares — an estimated $36K sold.

Longfellow Investment Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $36K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Longfellow Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Longfellow Investment Management sold 533 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $36K.
Longfellow Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Longfellow Investment Management's Global Blood Therapeutics, Inc. position peaked at $36K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Longfellow Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.